Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GCS in advanced biliary tract cancer
NCT01284413Phase 2Completed
- Sponsor
- Kansai Hepatobiliary Oncology Group
- Start
- Dec 2010
- Primary completion
- Aug 2012
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in biliary tract cancer (BTC), sponsored by Kansai Hepatobiliary Oncology Group. Started Dec 2010; status: completed.
02
Drugs
tegafur
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT01284413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01284413.